iRhythm Holdings, Inc.
IRTCHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeiRhythm Holdings, Inc. iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to. With a market capitalization of $3.47B, it sits in mid-cap territory. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Market Cap
$3.47B
Beta
1.33
P/E (TTM)
—
P/E (Fwd)
100.35
EPS (TTM)
$-0.85
EPS (Fwd)
$1.05
ROE
-22.4%
ROA
-1.1%
Cash
$549.6M
Total Debt
$729.3M
Free CF
$57.0M
52W Change
-26.7%
Annual Financials
Cash vs Debt
iRhythm Holdings, Inc. carries $729.3M in total debt against $549.6M in cash reserves — debt is modestly above the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $57.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -22.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $410.9M (2022) to $747.1M (2025), reflecting a 82% increase over the period.
As with any equity investment, IRTC carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing IRTC.